Efficacy and safety of liraglutide compared to sulphonylurea during Ramadan in patients with type 2 diabetes (LIRA‐Ramadan): a randomized trial

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 18, Iss. 10, 2016-10 ,pp. : 1025-1033

John Wiley & Sons Inc

Access to resources Recommend Favorite

Guidelines for screening and managing diabetes in the United States of America [Pautas para el tamizaje y el manejo de la diabetes en Estados Unidos de América]

By  

Revista Panamericana de Salud Pública/Pan American Journal of Public Health, Vol. 10, Iss. 5, 2001-11 ,pp. : 358-360

Pan American Health Organization (PAHO)

Access to resources Recommend Favorite

Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: a five-country observational study

By Aravind S.R.   Tayeb Khaled Al   Ismail Shaiful Bahari   Shehadeh Naim   Kaddaha Ghaida   Liu Rose   Balshaw Robert   Lesnikova Nadia   Heisel Olaf   Girman Cynthia J.   Musser Bret J.   Davies Michael J.   Katzeff Harvey L.   Engel Samuel S.   Radican Larry  

Current Medical Research and Opinion, Vol. 27, Iss. 6, 2011-06 ,pp. : 1237-1242

Informa Healthcare

Access to resources Recommend Favorite

Treatment adherence with vildagliptin compared to sulphonylurea as add-on to metformin in Muslim patients with type 2 diabetes mellitus fasting during Ramadan

By Hanif W.  

Current Medical Research and Opinion, Vol. 29, Iss. 7, 2013-07 ,pp. : 807-811

Informa Healthcare

Access to resources Recommend Favorite

Diabetes telemonitoring reduces the risk of hypoglycaemia during Ramadan: a pilot randomized controlled study

By  

DIABETIC MEDICINE, Vol. 32, Iss. 12, 2015-12 ,pp. : 1658-1661

John Wiley & Sons Inc

Access to resources Recommend Favorite